NEW YORK (Reuters) - As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on ...

The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.

As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on Friday, Wall Street ...

Pharmacies prescribe big changes, Apple and Nvidia keep tech stocks rally going, canceling subscriptions gets easier ...

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

The S&P 500 Index set another all-time high this week, and as our trading session ended Oct. 18, 2024, its closing figures ...

For three years in a row, Karen Lynch was ranked No. 1 on Fortune's Most Powerful Women list. Her job as CEO of CVS Health ...

The Washington Post reports that intense public backlash and a lawsuit led the FDA to reconsider its declaration, made two weeks ago, that the shortage of weight-loss drugs Mounjaro and Zepbound is ...

David Joyner will take over as the company heads in a new direction to stabilize its finances. CVS Health’s reshuffling has ...

In the past couple of weeks, the embattled CVS Health has provided some significant updates about its workforce in Connecticut. Their most-pressing question is one that company officials have declined ...

CVS, RiteAid and Walgreens — are in the midst of some pretty tough times lately. And experts in both the retail and health ...

Some 200,000 mail carriers have reached a tentative contract deal with the U.S. Postal Service that includes backdated pay ...